Sancho Saldaña, A., Gil-Sánchez, A., González Mingot, C., Peralta Moncusí, S., Solana Moga, M. J., Torres Cabestany, P., . . . Brieva Ruiz, L. (2023). Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study.
Citación estilo ChicagoSancho Saldaña, Agustín, et al. Seroprevalence of SARS-CoV-2 in Patients With Multiple Sclerosis Under Disease-Modifying Therapies: A Multi-Centre Study. 2023.
Cita MLASancho Saldaña, Agustín, et al. Seroprevalence of SARS-CoV-2 in Patients With Multiple Sclerosis Under Disease-Modifying Therapies: A Multi-Centre Study. 2023.
Precaución: Estas citas no son 100% exactas.